Cochlear
Cochlear is a leading manufacturer of cochlear implant devices, holding approximately 60% of the global market share. The company specializes in developing implantable hearing solutions that significantly improve the quality of life for individuals with hearing loss. Its primary products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In developed markets, where cochlear implants are considered the standard care for children with severe to profound hearing loss, the company generates around 80% of its revenue. Additionally, Cochlear targets the growing population of seniors with hearing challenges in these markets. Revenue distribution in fiscal 2020 showed that 49% came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific region. Overall, Cochlear is committed to transforming the understanding and treatment of hearing loss.
9 past transactions
Oticon Medical AB
Acquisition in 2022
Oticon Medical offers bone anchored hearing systems and cochlear implant solutions.
Seer
Series A in 2021
Seer is a medical technology company founded in 2016 and headquartered in Melbourne, Victoria. It specializes in the diagnosis and management of neurological conditions, particularly epilepsy. The company's innovative approach combines wearable devices with a cloud platform and machine learning systems to deliver hospital-standard monitoring and diagnosis in a home setting. Seer's technology enables continuous monitoring of epilepsy, cardiac disease, sleep, and other health conditions, capturing medical events through a mobile application. This platform allows patients to receive personalized insights, predictions, and alerts, ultimately empowering them to better manage their health by identifying long-term illness patterns.
Nyxoah
Corporate Round in 2020
Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Nyxoah's primary product, the Genio system, is a CE-Mark validated bilateral neurostimulation therapy designed to address OSA, which is recognized as the most prevalent sleep disordered breathing condition. OSA is linked to various health risks, including increased mortality and comorbidities such as cardiovascular diseases, depression, and stroke. The Genio system emphasizes user-centered design and represents a next-generation approach to treating this critical health issue.
Nyxoah
Series C in 2018
Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Nyxoah's primary product, the Genio system, is a CE-Mark validated bilateral neurostimulation therapy designed to address OSA, which is recognized as the most prevalent sleep disordered breathing condition. OSA is linked to various health risks, including increased mortality and comorbidities such as cardiovascular diseases, depression, and stroke. The Genio system emphasizes user-centered design and represents a next-generation approach to treating this critical health issue.
EarLens
Series C in 2017
EarLens is a privately held medical technology company focused on enhancing the hearing experience for individuals with hearing loss. The firm has pioneered the Earlens Contact Hearing Solution, a groundbreaking device that directly activates the natural hearing process. This innovative system utilizes low-frequency radio signals and a small lens placed on the eardrum to vibrate it, allowing for superior sound quality and a broader bandwidth than traditional hearing aids. Unlike conventional devices that amplify sound, the Earlens solution delivers sound directly to the eardrum, thereby minimizing feedback and ensuring clear hearing in various environments. The second generation of this technology received FDA clearance in 2019, marking a significant advancement in the standard of care for hearing performance.
Sycle
Acquisition in 2017
Sycle is a company that specializes in audiology practice management software, aimed at enhancing the operational efficiency of hearing care clinics. Its cloud-based platform integrates various services, including patient clinical data management, financing, reimbursement, and marketing campaigns, alongside front and back office functions. This comprehensive approach enables audiologists to focus more on patient care while minimizing administrative burdens. By streamlining these processes, Sycle supports hearing professionals in providing better service to their patients.
EarLens
Series C in 2016
EarLens is a privately held medical technology company focused on enhancing the hearing experience for individuals with hearing loss. The firm has pioneered the Earlens Contact Hearing Solution, a groundbreaking device that directly activates the natural hearing process. This innovative system utilizes low-frequency radio signals and a small lens placed on the eardrum to vibrate it, allowing for superior sound quality and a broader bandwidth than traditional hearing aids. Unlike conventional devices that amplify sound, the Earlens solution delivers sound directly to the eardrum, thereby minimizing feedback and ensuring clear hearing in various environments. The second generation of this technology received FDA clearance in 2019, marking a significant advancement in the standard of care for hearing performance.
Otologics
Acquisition in 2009
Otologics, LLC, a medical device company, develops and manufactures amplification products that are designed to improve communication of life for individuals with hearing loss. It offers Carina, an implantable treatment option for hearing loss. The company was founded in 1996 and is headquartered in Boulder, Colorado.
Cochlear Bone Anchored Solutions
Acquisition in 2005
Cochlear Bone Anchored Solutions manufactures, and sells medical systems for hearing and facial rehabilitation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.